$0.1520
0.0789.29%
After Hours: May 20, 7:41 PM EDT
Comments
Loading...
NRX Pharmaceuticals Analyst Ratings and Price Targets | NASDAQ:NRXPW | Benzinga
NRX Pharmaceuticals Corp has a consensus price target of $567.61 based on the ratings of 38 analysts. The high is $1350 issued by HSBC on May 10, 2024<. The low is $100 issued by Deutsche Bank on August 5, 2024. The 3 most-recent analyst ratings were released by New Street Research, Goldman Sachs, and Deutsche Bank on August 6, 2024, August 5, 2024, and August 5, 2024, respectively. With an average price target of $118.33 between New Street Research, Goldman Sachs, and Deutsche Bank, there's an implied 0.21% upside for NRX Pharmaceuticals Corp from these most-recent analyst ratings.
Analyst Ratings for NRX Pharmaceuticals
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
No data available to display | |||||||||
FAQ
What is the target price for NRX Pharmaceuticals (NRXPW) stock?
There is no price target for NRX Pharmaceuticals
What is the most recent analyst rating for NRX Pharmaceuticals (NRXPW)?
There is no analyst for NRX Pharmaceuticals
When was the last upgrade for NRX Pharmaceuticals (NRXPW)?
There is no last upgrade for NRX Pharmaceuticals
When was the last downgrade for NRX Pharmaceuticals (NRXPW)?
There is no last downgrade for NRX Pharmaceuticals.
When is the next analyst rating going to be posted or updated for NRX Pharmaceuticals (NRXPW)?
There is no next analyst rating for NRX Pharmaceuticals.
Is the Analyst Rating NRX Pharmaceuticals (NRXPW) correct?
There is no next analyst rating for NRX Pharmaceuticals.
Browse analyst ratings and price targets on all stocks.
